Drug Discovery
Author:
Ramakrishnan Geetha
Publisher
Springer Netherlands
Reference58 articles.
1. Accelrys Inc.
http://www.accelrys.com
2. Adams CP, Brantner VV. Estimating the cost of new drug development: Is it really $802 million? Health Aff. 2006;25:420–8.
3. Barillari C, Marcou G, Rognan D. Hot-spots-guided receptor-based pharmacophores (HSP harm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores. J Chem Inf Model. 2008;48:1396–410.
4. Barnum D, Greene J, Smellie A, Sprague P. Identification of common functional configurations among molecules. J Chem Inf Comput Sci. 1996;36:563–71.
5. Blum KA, Advani A, Fernandez L, Van Der Jagt R, Brandwein J, Kambhampati S, Kassis J, Davis M, Bonfils C, Dubay M, Dumouchel J, Drouin M, Lucas DM, Martell RE, Byrd JC. Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia. Br J Haematol. 2009;147(4):507–14.